Status:
COMPLETED
Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation
Lead Sponsor:
Lars Wik
Collaborating Sponsors:
University of Stavanger
Oslo University Hospital
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Severe acute respiratory syndrome (SARS) SARS-Cov-2 disease (COVID-19) is an infectious disease caused by a coronavirus. The pandemic first described in Wuhan, China, has since spread across the whole...
Detailed Description
Severe acute respiratory syndrome (SARS) SARS-Cov-2 disease (COVID-19) is an infectious disease caused by a coronavirus. The pandemic first described in Wuhan, China, has since spread across the whole...
Eligibility Criteria
Inclusion
- Valid informed consent.
- All Covid 19 positive patients age ≥18 years who are under care at home for Covid 19 infection.
- Patients with typical Covid 19 clinical symptoms where a test has not been taken may also be included if a test later is positive.
- Able to log into internet.
Exclusion
- Age \<18 years.
- Covid 19 negative.
- Internals in prison.
- Individuals living in special homes due to need of care.
- Refusal of participation.
- Comorbidity that hinder the patient to run the system.
Key Trial Info
Start Date :
April 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04335097
Start Date
April 22 2020
End Date
September 20 2022
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lillestrom legevakt
Lillestrøm, Norway